Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients
Clinical trial NCT05565573 · UNKNOWN
Trial details
- NCT number
- NCT05565573
- Sponsor
- Hua Li
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-07-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.